Pramipexole use and the risk of pneumonia
Identifieur interne : 001149 ( Main/Exploration ); précédent : 001148; suivant : 001150Pramipexole use and the risk of pneumonia
Auteurs : Pierre Ernst [Canada] ; Christel Renoux [Canada] ; Sophie Dell'Aniello [Canada] ; Samy Suissa [Canada]Source :
- BMC Neurology [ 1471-2377 ] ; 2012.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Antiparkinson Agents (therapeutic use), Benzothiazoles (therapeutic use), Cohort Studies, Comorbidity, Drug-Related Side Effects and Adverse Reactions (mortality), Female, Humans, Incidence, Male, Middle Aged, Parkinson Disease (drug therapy), Parkinson Disease (mortality), Pneumonia (mortality), Registries, Risk Factors, United Kingdom (epidemiology).
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Benzothiazoles.
- drug therapy : Parkinson Disease.
- epidemiology : United Kingdom.
- mortality : Drug-Related Side Effects and Adverse Reactions, Parkinson Disease, Pneumonia.
- Adult, Aged, Aged, 80 and over, Cohort Studies, Comorbidity, Female, Humans, Incidence, Male, Middle Aged, Registries, Risk Factors.
Abstract
Patients with Parkinson's disease have an elevated risk of pneumonia and randomized trials suggest that this risk may be increased with the dopamine agonist pramipexole. It is uncertain whether pramipexole or other dopamine agonists increase the risk of pneumonia.
We used the United Kingdom's General Practice Research Database (GPRD) to identify users of anti-parkinsonian drugs, 40–89 years of age, between 1997 and 2009. Using a nested case–control approach, all incident cases hospitalised for pneumonia were matched with up to ten controls selected among the cohort members. Rate ratios (RR) and 95% confidence intervals (CI) of pneumonia associated with current use of dopamine agonists were estimated using conditional logistic regression, adjusted for covariates.
The cohort included 13,183 users of anti-parkinsonian drugs, with 1,835 newly diagnosed with pneumonia during follow-up (rate 40.9 per 1,000 per year). The rate of pneumonia was not increased with the current use of pramipexole (RR 0.76; 95% CI: 0.57-1.02), compared with no use. The use of pramipexole was not associated with an increased rate of pneumonia when compared with all other dopamine agonists collectively (RR 0.85; 95% CI: 0.62-1.17).
The use of pramipexole does not appear to increase the risk of pneumonia.
Url:
DOI: 10.1186/1471-2377-12-113
PubMed: 23020246
PubMed Central: 3522019
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000491
- to stream Pmc, to step Curation: 000491
- to stream Pmc, to step Checkpoint: 000780
- to stream PubMed, to step Corpus: 000A22
- to stream PubMed, to step Curation: 000A22
- to stream PubMed, to step Checkpoint: 000A22
- to stream Ncbi, to step Merge: 001265
- to stream Ncbi, to step Curation: 001265
- to stream Ncbi, to step Checkpoint: 001265
- to stream Main, to step Merge: 001171
- to stream Main, to step Curation: 001149
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pramipexole use and the risk of pneumonia</title><author><name sortKey="Ernst, Pierre" sort="Ernst, Pierre" uniqKey="Ernst P" first="Pierre" last="Ernst">Pierre Ernst</name><affiliation wicri:level="1"><nlm:aff id="I1">Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2</wicri:regionArea><wicri:noRegion>H3T 1E2</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="I2">Division of Pulmonary Medicine, Jewish General Hospital, Montreal, QC, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Pulmonary Medicine, Jewish General Hospital, Montreal, QC</wicri:regionArea><wicri:noRegion>QC</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:aff id="I3">Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, QC, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, QC</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Renoux, Christel" sort="Renoux, Christel" uniqKey="Renoux C" first="Christel" last="Renoux">Christel Renoux</name><affiliation wicri:level="1"><nlm:aff id="I1">Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2</wicri:regionArea><wicri:noRegion>H3T 1E2</wicri:noRegion></affiliation></author><author><name sortKey="Dell Aniello, Sophie" sort="Dell Aniello, Sophie" uniqKey="Dell Aniello S" first="Sophie" last="Dell'Aniello">Sophie Dell'Aniello</name><affiliation wicri:level="1"><nlm:aff id="I1">Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2</wicri:regionArea><wicri:noRegion>H3T 1E2</wicri:noRegion></affiliation></author><author><name sortKey="Suissa, Samy" sort="Suissa, Samy" uniqKey="Suissa S" first="Samy" last="Suissa">Samy Suissa</name><affiliation wicri:level="1"><nlm:aff id="I1">Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2</wicri:regionArea><wicri:noRegion>H3T 1E2</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:aff id="I3">Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, QC, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, QC</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23020246</idno><idno type="pmc">3522019</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522019</idno><idno type="RBID">PMC:3522019</idno><idno type="doi">10.1186/1471-2377-12-113</idno><date when="2012">2012</date><idno type="wicri:Area/Pmc/Corpus">000491</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000491</idno><idno type="wicri:Area/Pmc/Curation">000491</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000491</idno><idno type="wicri:Area/Pmc/Checkpoint">000780</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000780</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">000A22</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A22</idno><idno type="wicri:Area/PubMed/Curation">000A22</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A22</idno><idno type="wicri:Area/PubMed/Checkpoint">000A22</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A22</idno><idno type="wicri:Area/Ncbi/Merge">001265</idno><idno type="wicri:Area/Ncbi/Curation">001265</idno><idno type="wicri:Area/Ncbi/Checkpoint">001265</idno><idno type="wicri:Area/Main/Merge">001171</idno><idno type="wicri:Area/Main/Curation">001149</idno><idno type="wicri:Area/Main/Exploration">001149</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Pramipexole use and the risk of pneumonia</title><author><name sortKey="Ernst, Pierre" sort="Ernst, Pierre" uniqKey="Ernst P" first="Pierre" last="Ernst">Pierre Ernst</name><affiliation wicri:level="1"><nlm:aff id="I1">Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2</wicri:regionArea><wicri:noRegion>H3T 1E2</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="I2">Division of Pulmonary Medicine, Jewish General Hospital, Montreal, QC, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Pulmonary Medicine, Jewish General Hospital, Montreal, QC</wicri:regionArea><wicri:noRegion>QC</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:aff id="I3">Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, QC, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, QC</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Renoux, Christel" sort="Renoux, Christel" uniqKey="Renoux C" first="Christel" last="Renoux">Christel Renoux</name><affiliation wicri:level="1"><nlm:aff id="I1">Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2</wicri:regionArea><wicri:noRegion>H3T 1E2</wicri:noRegion></affiliation></author><author><name sortKey="Dell Aniello, Sophie" sort="Dell Aniello, Sophie" uniqKey="Dell Aniello S" first="Sophie" last="Dell'Aniello">Sophie Dell'Aniello</name><affiliation wicri:level="1"><nlm:aff id="I1">Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2</wicri:regionArea><wicri:noRegion>H3T 1E2</wicri:noRegion></affiliation></author><author><name sortKey="Suissa, Samy" sort="Suissa, Samy" uniqKey="Suissa S" first="Samy" last="Suissa">Samy Suissa</name><affiliation wicri:level="1"><nlm:aff id="I1">Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, 3755 Cote Ste-Catherine, Montreal, QC, H3T 1E2</wicri:regionArea><wicri:noRegion>H3T 1E2</wicri:noRegion></affiliation><affiliation wicri:level="4"><nlm:aff id="I3">Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, QC, Canada</nlm:aff><country xml:lang="fr">Canada</country><wicri:regionArea>Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, QC</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author></analytic><series><title level="j">BMC Neurology</title><idno type="eISSN">1471-2377</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antiparkinson Agents (therapeutic use)</term><term>Benzothiazoles (therapeutic use)</term><term>Cohort Studies</term><term>Comorbidity</term><term>Drug-Related Side Effects and Adverse Reactions (mortality)</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (mortality)</term><term>Pneumonia (mortality)</term><term>Registries</term><term>Risk Factors</term><term>United Kingdom (epidemiology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Benzothiazoles</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>United Kingdom</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Drug-Related Side Effects and Adverse Reactions</term><term>Parkinson Disease</term><term>Pneumonia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Comorbidity</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Registries</term><term>Risk Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Patients with Parkinson's disease have an elevated risk of pneumonia and randomized trials suggest that this risk may be increased with the dopamine agonist pramipexole. It is uncertain whether pramipexole or other dopamine agonists increase the risk of pneumonia.</p></sec><sec><title>Methods</title><p>We used the United Kingdom's General Practice Research Database (GPRD) to identify users of anti-parkinsonian drugs, 40–89 years of age, between 1997 and 2009. Using a nested case–control approach, all incident cases hospitalised for pneumonia were matched with up to ten controls selected among the cohort members. Rate ratios (RR) and 95% confidence intervals (CI) of pneumonia associated with current use of dopamine agonists were estimated using conditional logistic regression, adjusted for covariates.</p></sec><sec><title>Results</title><p>The cohort included 13,183 users of anti-parkinsonian drugs, with 1,835 newly diagnosed with pneumonia during follow-up (rate 40.9 per 1,000 per year). The rate of pneumonia was not increased with the current use of pramipexole (RR 0.76; 95% CI: 0.57-1.02), compared with no use. The use of pramipexole was not associated with an increased rate of pneumonia when compared with all other dopamine agonists collectively (RR 0.85; 95% CI: 0.62-1.17).</p></sec><sec><title>Conclusions</title><p>The use of pramipexole does not appear to increase the risk of pneumonia.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="De Rijk, Mc" uniqKey="De Rijk M">MC de Rijk</name></author><author><name sortKey="Breteler, Mm" uniqKey="Breteler M">MM Breteler</name></author><author><name sortKey="Graveland, Ga" uniqKey="Graveland G">GA Graveland</name></author><author><name sortKey="Ott, A" uniqKey="Ott A">A Ott</name></author><author><name sortKey="Grobbee, De" uniqKey="Grobbee D">DE Grobbee</name></author><author><name sortKey="Van Der Meche, Fg" uniqKey="Van Der Meche F">FG van der Meche</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Twelves, D" uniqKey="Twelves D">D Twelves</name></author><author><name sortKey="Perkins, Ks" uniqKey="Perkins K">KS Perkins</name></author><author><name sortKey="Counsell, C" uniqKey="Counsell C">C Counsell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fall, Pa" uniqKey="Fall P">PA Fall</name></author><author><name sortKey="Saleh, A" uniqKey="Saleh A">A Saleh</name></author><author><name sortKey="Fredrickson, M" uniqKey="Fredrickson M">M Fredrickson</name></author><author><name sortKey="Olsson, Je" uniqKey="Olsson J">JE Olsson</name></author><author><name sortKey="Granerus, Ak" uniqKey="Granerus A">AK Granerus</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Morgante, L" uniqKey="Morgante L">L Morgante</name></author><author><name sortKey="Salemi, G" uniqKey="Salemi G">G Salemi</name></author><author><name sortKey="Meneghini, F" uniqKey="Meneghini F">F Meneghini</name></author><author><name sortKey="Di Rosa, Ae" uniqKey="Di Rosa A">AE Di Rosa</name></author><author><name sortKey="Epifanio, A" uniqKey="Epifanio A">A Epifanio</name></author><author><name sortKey="Grigoletto, F" uniqKey="Grigoletto F">F Grigoletto</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fernandez, Hh" uniqKey="Fernandez H">HH Fernandez</name></author><author><name sortKey="Lapane, Kl" uniqKey="Lapane K">KL Lapane</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mehanna, R" uniqKey="Mehanna R">R Mehanna</name></author><author><name sortKey="Jankovic, J" uniqKey="Jankovic J">J Jankovic</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dies, I" uniqKey="Dies I">I Dies</name></author><author><name sortKey="Hoffmann, H" uniqKey="Hoffmann H">H Hoffmann</name></author><author><name sortKey="Albrecht, S" uniqKey="Albrecht S">S Albrecht</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jick, H" uniqKey="Jick H">H Jick</name></author><author><name sortKey="Jick, Ss" uniqKey="Jick S">SS Jick</name></author><author><name sortKey="Derby, Le" uniqKey="Derby L">LE Derby</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jick, Ss" uniqKey="Jick S">SS Jick</name></author><author><name sortKey="Kaye, Ja" uniqKey="Kaye J">JA Kaye</name></author><author><name sortKey="Vasilakis Scaramozza, C" uniqKey="Vasilakis Scaramozza C">C Vasilakis-Scaramozza</name></author><author><name sortKey="Garcia Rodriguez, La" uniqKey="Garcia Rodriguez L">LA Garcia Rodriguez</name></author><author><name sortKey="Ruigomez, A" uniqKey="Ruigomez A">A Ruigomez</name></author><author><name sortKey="Meier, Cr" uniqKey="Meier C">CR Meier</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Walley, T" uniqKey="Walley T">T Walley</name></author><author><name sortKey="Mantgani, A" uniqKey="Mantgani A">A Mantgani</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schade, R" uniqKey="Schade R">R Schade</name></author><author><name sortKey="Andersohn, F" uniqKey="Andersohn F">F Andersohn</name></author><author><name sortKey="Suissa, S" uniqKey="Suissa S">S Suissa</name></author><author><name sortKey="Haverkamp, W" uniqKey="Haverkamp W">W Haverkamp</name></author><author><name sortKey="Garbe, E" uniqKey="Garbe E">E Garbe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sarkar, M" uniqKey="Sarkar M">M Sarkar</name></author><author><name sortKey="Hennessy, S" uniqKey="Hennessy S">S Hennessy</name></author><author><name sortKey="Yang, Yx" uniqKey="Yang Y">YX Yang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schlienger, Rg" uniqKey="Schlienger R">RG Schlienger</name></author><author><name sortKey="Fedson, Ds" uniqKey="Fedson D">DS Fedson</name></author><author><name sortKey="Jick, Ss" uniqKey="Jick S">SS Jick</name></author><author><name sortKey="Jick, H" uniqKey="Jick H">H Jick</name></author><author><name sortKey="Meier, Cr" uniqKey="Meier C">CR Meier</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jokinen, C" uniqKey="Jokinen C">C Jokinen</name></author><author><name sortKey="Heiskanen, L" uniqKey="Heiskanen L">L Heiskanen</name></author><author><name sortKey="Juvonen, H" uniqKey="Juvonen H">H Juvonen</name></author><author><name sortKey="Kallinen, S" uniqKey="Kallinen S">S Kallinen</name></author><author><name sortKey="Karkola, K" uniqKey="Karkola K">K Karkola</name></author><author><name sortKey="Korppi, M" uniqKey="Korppi M">M Korppi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Johnston, Bt" uniqKey="Johnston B">BT Johnston</name></author><author><name sortKey="Li, Q" uniqKey="Li Q">Q Li</name></author><author><name sortKey="Castell, Ja" uniqKey="Castell J">JA Castell</name></author><author><name sortKey="Castell, Do" uniqKey="Castell D">DO Castell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bushmann, M" uniqKey="Bushmann M">M Bushmann</name></author><author><name sortKey="Dobmeyer, Sm" uniqKey="Dobmeyer S">SM Dobmeyer</name></author><author><name sortKey="Leeker, L" uniqKey="Leeker L">L Leeker</name></author><author><name sortKey="Perlmutter, Js" uniqKey="Perlmutter J">JS Perlmutter</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gross, Rd" uniqKey="Gross R">RD Gross</name></author><author><name sortKey="Atwood, Cw" uniqKey="Atwood C">CW Atwood</name></author><author><name sortKey="Ross, Sb" uniqKey="Ross S">SB Ross</name></author><author><name sortKey="Eichhorn, Ka" uniqKey="Eichhorn K">KA Eichhorn</name></author><author><name sortKey="Olszewski, Jw" uniqKey="Olszewski J">JW Olszewski</name></author><author><name sortKey="Doyle, Pj" uniqKey="Doyle P">PJ Doyle</name></author></analytic></biblStruct></listBibl></div1></back></TEI><affiliations><list><country><li>Canada</li></country><region><li>Québec</li></region><settlement><li>Montréal</li></settlement><orgName><li>Université McGill</li></orgName></list><tree><country name="Canada"><noRegion><name sortKey="Ernst, Pierre" sort="Ernst, Pierre" uniqKey="Ernst P" first="Pierre" last="Ernst">Pierre Ernst</name></noRegion><name sortKey="Dell Aniello, Sophie" sort="Dell Aniello, Sophie" uniqKey="Dell Aniello S" first="Sophie" last="Dell'Aniello">Sophie Dell'Aniello</name><name sortKey="Ernst, Pierre" sort="Ernst, Pierre" uniqKey="Ernst P" first="Pierre" last="Ernst">Pierre Ernst</name><name sortKey="Ernst, Pierre" sort="Ernst, Pierre" uniqKey="Ernst P" first="Pierre" last="Ernst">Pierre Ernst</name><name sortKey="Renoux, Christel" sort="Renoux, Christel" uniqKey="Renoux C" first="Christel" last="Renoux">Christel Renoux</name><name sortKey="Suissa, Samy" sort="Suissa, Samy" uniqKey="Suissa S" first="Samy" last="Suissa">Samy Suissa</name><name sortKey="Suissa, Samy" sort="Suissa, Samy" uniqKey="Suissa S" first="Samy" last="Suissa">Samy Suissa</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001149 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001149 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:3522019
|texte= Pramipexole use and the risk of pneumonia
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23020246" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |